Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F88QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,451
Award facts
- Contract value 100% obligated
- $11,451.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,451.25 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure treatment, representing part of the company's extensive pharmaceutical supply portfolio to federal medical systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the prime IDC and serves as a critical pharmaceutical vendor supplying military healthcare programs globally with brand-name and generic medications, vaccines, specialty drugs, and medical supplies. The company's federal contract portfolio demonstrates its established capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for Defense Health Agency customers and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F88QN?
SPE2DR26F88QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F88QN worth?
The government has obligated $11,451 on SPE2DR26F88QN.
Is contract SPE2DR26F88QN an order under another contract?
Yes. SPE2DR26F88QN is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88QN competed?
The extent of competition for SPE2DR26F88QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award